Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02096354
Title A Phase 2 Randomized, Open-Label Study of RRx-001 vs Regorafenib in Subjects With Metastatic Colorectal Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors EpicentRx, Inc.
Indications

colon adenocarcinoma

rectum adenocarcinoma

Therapies

Regorafenib

Age Groups: adult
Covered Countries USA


No variant requirements are available.